Both groups show reduced abundance of intestinal bacteria Roseburia , including Ruminococcus gnavus and Ruminococcus , while the abundance of Blautia increases
Van den Bulck, K
Factors influencing outcomes may include: Age Injury severity Lifestyle habits Nutrition Overall health status Treatment adherence No outcome can be guaranteed
Emerging evidence demonstrates that GLP-1 receptor agonists may provide significant benefits for liver health, particularly in patients with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease or NAFLD) and its inflammatory subtype, metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH)
Tirzepatide (MOUNJARO) is a once-weekly subcutaneous injectable agent first authorized for T2DM and later extended to the management of obesity or overweight with at least one weight-related comorbidity, thereby aligning its therapeutic scope with subcutaneous liraglutide and semaglutide [34,35,36]
However, the exact amount should be based on blood test results and professional advice